NGSベースのRNAシークエンシング市場：製品・サービス、技術、用途、エンドユーザー別-2025～2030年の世界予測

NGSベースのRNAシークエンシング市場は、2023年に23億2,000万米ドルと評価され、2024年には26億7,000万米ドルに達すると予測され、CAGR 17.32％で成長し、2030年には71億2,000万米ドルに達すると予測されています。

トランスクリプトームの包括的な分析を可能にするNGSベースのRNAシークエンシングは、遺伝子発現の詳細な洞察、新規転写産物の発見、遺伝子制御メカニズムの理解促進を提供することで、ゲノミクス研究に革命を起こすことを約束します。RNAシーケンシングの必要性は、個別化医療を推進し、新たな治療標的を同定し、複雑な生物学的システムを理解するために不可欠な、正確で高スループットのデータを提供するその能力から生じる。アプリケーションは腫瘍学から神経学に及び、疾患研究、診断、創薬において重要な役割を果たしています。最終用途市場は、学術・研究機関、臨床診断ラボ、製薬会社、バイオテクノロジー会社など多岐にわたり、応用範囲の広さを示しています。市場の成長を支えているのは、個別化医療への嗜好の高まり、ゲノム研究への資金提供の増加、コスト削減と利用しやすさを向上させるシーケンス技術の技術的進歩などの要因です。最新のビジネス機会としては、データ分析のためのAIと機械学習の統合、非モデル生物や研究の少ない疾患におけるRNAシーケンシングの応用の強化、バイオマーカー探索や精密医療における有用性の拡大などが挙げられます。企業は、イノベーションを推進し、独自のシーケンスアプリケーションを探求するために、研究機関との連携に注力すべきです。しかし、初期コストの高さ、データの複雑さ、先進的インフラの必要性などの制約が市場拡大の課題となっています。遺伝子データに関する規制の複雑さや倫理的な懸念が、状況をさらに複雑にしています。革新の機会は、より迅速でコスト効率の高いソリューションを提供するためにシーケンス技術を進歩させること、解釈を合理化するために堅牢なデータ分析ツールを開発すること、アクセスを民主化するためにユーザーフレンドリーなプラットフォームに注力することにあります。市場が成熟するにつれ、データストレージと計算のためのクラウドコンピューティングの活用が不可欠となり、戦略的な産学連携が新たな機会を探る上で中心となると考えられます。RNAシークエンシング市場はダイナミックで急速に進化しており、医療の革新や研究の最前線との整合性が高まるにつれて、力強い成長の可能性が顕著になっています。

市場力学：急速に進化するNGSベースのRNAシークエンシング市場の主要市場洞察を公開

NGSベースのRNAシークエンシング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 次世代シーケンサーの採用急増
  • 精密医療の堅調な成長とRNAシーケンス助成金の増加
  • 先進的シーケンスベースの診断に対する需要の増加
• 市場抑制要因
  • NGS装置のコストが高い
• 市場機会
  • RNAシーケンシングの技術進歩
  • RNAシーケンシングに関する研究活動の増加
• 市場課題
  • 熟練した人材の不足

ポーターのファイブフォース：NGSベースのRNAシークエンシング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：NGSベースのRNAシークエンシング市場における外部からの影響の把握

外部マクロ環境要因は、NGSベースのRNAシークエンシング市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：NGSベースのRNAシークエンシング市場における競合情勢の把握

NGSベースのRNAシークエンシング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：NGSベースのRNAシークエンシング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、NGSベースのRNAシークエンシング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：NGSベースのRNAシークエンシング市場における成功への道筋を描く

NGSベースのRNAシークエンシング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 次世代シーケンシングの導入の急増
    • 精密医療の堅調な成長とRNAシーケンシング助成金の増加
    • 先進的シーケンスベースの診断に対する需要の増加
  • 抑制要因
    • NGS機器のコストは高い
  • 機会
    • RNAシークエンシングの技術的進歩
    • RNAシークエンシングに関する調査活動の増加
  • 課題
    • 熟練した人材の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 NGSベースのRNAシークエンシング市場：製品・サービス別

• イントロダクション
• データ分析
• RNAシーケンシングプラットフォームと消耗品
• RNAシーケンシングサービス
• サンプル調製製品
• ストレージと管理

第7章 NGSベースのRNAシークエンシング市場：技術別

• イントロダクション
• イオン半導体シーケンシング
• ナノポアシーケンシング
• 合成によるシーケンシング
• 単一分子リアルタイムシーケンシング

第8章 NGSベースのRNAシークエンシング市場：用途別

• イントロダクション
• De Novoトランスクリプトームアセンブリ
• 発現プロファイリング分析
• 小規模RNAシーケンシング
• 変異体コールとトランスクリプトームエピジェネティクス

第9章 NGSベースのRNAシークエンシング市場：エンドユーザー別

• イントロダクション
• 病院・クリニック
• 製薬・バイオテクノロジー企業
• 研究と学術

第10章 南北アメリカのNGSベースのRNAシークエンシング市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のNGSベースのRNAシークエンシング市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのNGSベースのRNAシークエンシング市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies
• Becton, Dickinson and Company
• BGI Group
• Eurofins Scientific
• F. Hoffmann-la Roche AG
• Genewiz by Brooks Automation, Inc.
• Hamilton Company
• Illumina, Inc.
• Merck KGaA
• Oxford Nanopore Technologies
• PerkinElmer, Inc.
• Psomagen
• Qiagen N.V.
• Takara Bio Inc.
• Thermo Fisher Scientific

LIST OF FIGURES

• FIGURE 1. NGS-BASED RNA-SEQUENCING MARKET RESEARCH PROCESS
• FIGURE 2. NGS-BASED RNA-SEQUENCING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. NGS-BASED RNA-SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NGS-BASED RNA-SEQUENCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NGS-BASED RNA-SEQUENCING MARKET DYNAMICS
• TABLE 7. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING PLATFORMS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STORAGE & MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DE NOVO TRANSCRIPTOME ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY EXPRESSION PROFILING ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SMALL RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY VARIANT CALLING & TRANSCRIPTOME EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 41. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 63. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 67. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 136. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 152. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 156. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 196. NGS-BASED RNA-SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

The NGS-Based RNA-Sequencing Market was valued at USD 2.32 billion in 2023, expected to reach USD 2.67 billion in 2024, and is projected to grow at a CAGR of 17.32%, to USD 7.12 billion by 2030.

NGS-Based RNA-Sequencing, which enables comprehensive analysis of the transcriptome, promises to revolutionize genomics research by providing detailed insights into gene expression, discovery of novel transcripts, and enhanced understanding of gene regulation mechanisms. The necessity of RNA-Sequencing arises from its ability to deliver precise, accurate, and high-throughput data essential for advancing personalized medicine, identifying new therapeutic targets, and understanding complex biological systems. Applications span from oncology to neurology, playing a crucial role in disease research, diagnostics, and drug discovery. End-use markets encompass academic and research institutes, clinical diagnostics labs, pharmaceutical and biotech companies, underscoring broad application versatility. Market growth is underpinned by factors such as increasing preference for personalized medicine, growing funding for genomic research, and technological advancements in sequencing technology that drive down costs and improve accessibility. Latest opportunities include integrating AI and machine learning for data analysis, enhancing the application of RNA-Sequencing in non-model organisms and less-studied diseases, and expanding its utility in biomarker discovery and precision medicine. Companies should focus on collaborations with research institutions to drive innovation and explore unique sequencing applications. However, limitations like high initial costs, data complexity, and the requisite for sophisticated infrastructure challenge market expansion. Regulatory complexities and ethical concerns related to genetic data further complicate the landscape. Innovation opportunities lie in advancing sequencing technologies to offer faster and more cost-efficient solutions, developing robust data analysis tools to streamline interpretations, and focusing on user-friendly platforms to democratize access. As the market matures, leveraging cloud computing for data storage and computation will be vital, and strategic industry-academic collaborations will be central to exploring nascent opportunities. The RNA-Sequencing market is dynamic and rapidly evolving, marked by robust growth potential as it aligns increasingly with healthcare innovation and research frontiers.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving NGS-Based RNA-Sequencing Market

The NGS-Based RNA-Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Surge in the adoption of next-generation sequencing
  • Robust growth of precision medicines and rising amount of RNA sequencing grants
  • Increasing demand for advanced sequencing-based diagnostics
• Market Restraints
  • Cost of NGS instruments is high
• Market Opportunities
  • Technological advancement in the RNA-Sequencing
  • Increasing research activities related to RNA-Sequencing
• Market Challenges
  • Unavailability of skilled manpower

Porter's Five Forces: A Strategic Tool for Navigating the NGS-Based RNA-Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the NGS-Based RNA-Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the NGS-Based RNA-Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the NGS-Based RNA-Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the NGS-Based RNA-Sequencing Market

A detailed market share analysis in the NGS-Based RNA-Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the NGS-Based RNA-Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the NGS-Based RNA-Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the NGS-Based RNA-Sequencing Market

A strategic analysis of the NGS-Based RNA-Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the NGS-Based RNA-Sequencing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Becton, Dickinson and Company, BGI Group, Eurofins Scientific, F. Hoffmann-la Roche AG, Genewiz by Brooks Automation, Inc., Hamilton Company, Illumina, Inc., Merck KGaA, Oxford Nanopore Technologies, PerkinElmer, Inc., Psomagen, Qiagen N.V., Takara Bio Inc., and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the NGS-Based RNA-Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Services, market is studied across Data Analysis, RNA Sequencing Platforms & Consumables, RNA Sequencing Services, Sample Preparation Products, and Storage & Management.
• Based on Technology, market is studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing By Synthesis, and Single-Molecule Real-Time Sequencing.
• Based on Application, market is studied across De Novo Transcriptome Assembly, Expression Profiling Analysis, Small RNA Sequencing, and Variant Calling & Transcriptome Epigenetics.
• Based on End-User, market is studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research & Academia.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surge in the adoption of next-generation sequencing
    • 5.1.1.2. Robust growth of precision medicines and rising amount of RNA sequencing grants
    • 5.1.1.3. Increasing demand for advanced sequencing-based diagnostics
  • 5.1.2. Restraints
    • 5.1.2.1. Cost of NGS instruments is high
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement in the RNA-Sequencing
    • 5.1.3.2. Increasing research activities related to RNA-Sequencing
  • 5.1.4. Challenges
    • 5.1.4.1. Unavailability of skilled manpower
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. NGS-Based RNA-Sequencing Market, by Product & Services

• 6.1. Introduction
• 6.2. Data Analysis
• 6.3. RNA Sequencing Platforms & Consumables
• 6.4. RNA Sequencing Services
• 6.5. Sample Preparation Products
• 6.6. Storage & Management

7. NGS-Based RNA-Sequencing Market, by Technology

• 7.1. Introduction
• 7.2. Ion Semiconductor Sequencing
• 7.3. Nanopore Sequencing
• 7.4. Sequencing By Synthesis
• 7.5. Single-Molecule Real-Time Sequencing

8. NGS-Based RNA-Sequencing Market, by Application

• 8.1. Introduction
• 8.2. De Novo Transcriptome Assembly
• 8.3. Expression Profiling Analysis
• 8.4. Small RNA Sequencing
• 8.5. Variant Calling & Transcriptome Epigenetics

9. NGS-Based RNA-Sequencing Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals & Clinics
• 9.3. Pharmaceutical & Biotechnology Companies
• 9.4. Research & Academia

10. Americas NGS-Based RNA-Sequencing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific NGS-Based RNA-Sequencing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa NGS-Based RNA-Sequencing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies
• 2. Becton, Dickinson and Company
• 3. BGI Group
• 4. Eurofins Scientific
• 5. F. Hoffmann-la Roche AG
• 6. Genewiz by Brooks Automation, Inc.
• 7. Hamilton Company
• 8. Illumina, Inc.
• 9. Merck KGaA
• 10. Oxford Nanopore Technologies
• 11. PerkinElmer, Inc.
• 12. Psomagen
• 13. Qiagen N.V.
• 14. Takara Bio Inc.
• 15. Thermo Fisher Scientific